MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s41999-025-01354-1

Медицинская библиотека · European geriatric medicine · 2025

Cardiovascular and glucose-lowering medication use among older adults: results from 9-year follow-up of the FINGER trial.

Sääskilahti Maria, Aarnio Emma, Levälahti Esko, Lehtisalo Jenni, Kivipelto Miia, Strandberg Timo, Antikainen Riitta, Soininen Hilkka, Laatikainen Tiina, Tuomilehto Jaakko, Solomon Alina, Mangialasche Francesca, Ngandu Tiia

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

PURPOSE: This study aimed to investigate the use of antihypertensive, lipid-lowering, antithrombotic, and glucose-lowering medication among the FINGER (Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) population during a 9-year follow-up. Also, the effects of the FINGER intervention on and differences between sexes and age groups in medication use were studied.

METHODS

Medication data for FINGER participants were retrieved from a national register annually, starting from the study baseline. FINGER was a two-year randomized controlled trial for older adults (n = 1259) at risk of cognitive impairment, who were randomly allocated to a multidomain lifestyle intervention or a control group. The intervention aimed at enhancing healthy lifestyle and to manage and monitor cardiovascular and metabolic risk factors. Generalized Estimation Equations were used to assess longitudinal changes in medication use.

RESULTS

Cardiovascular and glucose-lowering medication use was common and increased over time among FINGER participants. The prevalences of medication use did not differ between the intervention and control groups. The use of cardiovascular and glucose-lowering medication was fairly similar between men and women. Older participants used more cardiovascular medication compared to younger participants throughout the follow-up.

CONCLUSION

The increasing use of cardiovascular and glucose-lowering medication in this older population at risk of cognitive impairment reflects increasing cardiovascular and diabetes morbidity, management of these risks and diseases through medication, and possible changes in medical practices. Before drawing further conclusions about the effect of the intervention on medication use, its effect on treatment adjustments should be studied.

TRIAL REGISTRATION: ClinicalTrials.gov, NCT01041989, retrospectively registered 04/01/2010.

Для цитирования: Sääskilahti Maria, Aarnio Emma, Levälahti Esko, Lehtisalo Jenni, Kivipelto Miia, Strandberg Timo, Antikainen Riitta, Soininen Hilkka, Laatikainen Tiina, Tuomilehto Jaakko, Solomon Alina, Mangialasche Francesca, Ngandu Tiia. Cardiovascular and glucose-lowering medication use among older adults: results from 9-year follow-up of the FINGER trial.. European geriatric medicine. 2025. DOI: 10.1007/s41999-025-01354-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.